ÂÜÀòÂÒÂ×

Amy Adelman House is currently the Head of Portfolio Strategy at Beacon Therapeutics. Previously, Amy Adelman held a similar position at AGTC and worked as a Senior Director at a gene therapy company. Amy has a strong background in business development, alliance management, and consulting across various organizations and industries. Amy Adelman holds an MBA from Duke University and a BA from The Johns Hopkins University.